The ROE as of December 2025 (TTM) for Dianthus Therapeutics, Inc. (DNTH) is -33.02%

According to Dianthus Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -33.02%. This represents a change of 286.03% compared to the average of -8.55% of the last 4 quarters.

Dianthus Therapeutics, Inc. (DNTH) Historical ROE (quarterly & annually)

How has DNTH ROE performed in the past?

The mean historical ROE of Dianthus Therapeutics, Inc. over the last ten years is -34.90%. The current -33.02% ROE has changed -5.38% with respect to the historical average. Over the past ten years (40 quarters), DNTH's ROE was at its highest in in the December 2022 quarter at 22.80%. The ROE was at its lowest in in the March 2023 quarter at -37.66%.

Dianthus Therapeutics, Inc. (DNTH) ROE by Quarter and Year

Discovering the peaks and valleys of Dianthus Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dianthus Therapeutics, Inc. (DNTH) Average ROE

How has DNTH ROE performed in the past?

The current ROE of Dianthus Therapeutics, Inc. (DNTH) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Dianthus Therapeutics, Inc. (DNTH) ROE vs. Peers

How is DNTH’s ROE compared to its peers?

Dianthus Therapeutics, Inc.’s ROE is greater than Enliven Therapeutics, Inc. (-29.15%), greater than Taysha Gene Therapies, Inc. (-67.26%), greater than Sana Biotechnology, Inc. (-115.33%), greater than Atai Beckley N.V (-107.86%), greater than Nektar Therapeutics (-356.81%), greater than AnaptysBio, Inc. (-1101.24%), greater than Oculis Holding AG (-90.60%), greater than BridgeBio Oncology Therapeutics Inc. (-77.14%), greater than Immatics N.V. (-23.26%), greater than Tourmaline Bio, Inc. (-30.50%),

Build a custom stock screener for Dianthus Therapeutics, Inc. (DNTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dianthus Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dianthus Therapeutics, Inc. (DNTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dianthus Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.